{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:45:05Z","timestamp":1792158305661,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous renal denervation (RDN) studies showed controversial results in reducing blood pressure. The aim of this study was to provide evidence supporting the effectiveness of laparoscopic-based renal denervation (L-RDN) in treating hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sixteen Beagle dogs were randomly divided into RDN group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) and sham group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094). Neurogenic hypertension was generated in all dogs via carotid artery route. L-RDN was performed in the RDN group, with sham operation performed as a control. Blood pressure (BP) changes were recorded at 2, 4, 6, and 8\u2009weeks after the procedure. Changes in serum creatinine (sCr), blood urea nitrogen (BUN) and level of norepinephrine (NE) were analyzed. Histological changes of kidney and renal arteries were also evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      BP and NE levels were significantly elevated after hypertension induction (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Systolic and diastolic BP of RDN group were decreased by 15.5\u2009mmHg and 7.3\u2009mmHg (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0021, respectively) at the eighth week after L-RDN. Invasive systolic and diastolic BP of RDN group were significantly decreased by 14.5\u2009mmHg and 15.3\u2009mmHg (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). In contrast, there was no significant decrease in blood pressure in the sham group. In addition, RDN group but not the sham group showed a significant decrease in NE levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), while no significant changes in sCr and BUN were observed in both groups. Pathological examinations showed no discernible damage, tear, or dissection to the renal arteries in RND group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>L-RDN lowered BP and NE levels in hypertensive dogs without affecting renal artery morphology and kidney function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-020-01546-6","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T14:03:52Z","timestamp":1591884232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Laparoscopic based renal denervation in a canine neurogenic hypertension model"],"prefix":"10.1186","volume":"20","author":[{"given":"Chunlai","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter R.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-0145","authenticated-orcid":false,"given":"Ting Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longsheng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"1546_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275\u201381.","journal-title":"Lancet"},{"key":"1546_CR2","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"HTNI Symplicity","year":"2010","unstructured":"Symplicity HTNI, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial. Lancet. 2010;376:1903\u20139.","journal-title":"Lancet"},{"key":"1546_CR3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393\u2013401.","journal-title":"N Engl J Med"},{"key":"1546_CR4","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1253\/circj.CJ-15-0150","volume":"79","author":"K Kario","year":"2015","unstructured":"Kario K, Ogawa H, Okumura K, et al. SYMPLICITY HTN-Japan - first randomized controlled trial of catheter-based renal denervation in Asian patients. Circ J. 2015;79:1222\u20139.","journal-title":"Circ J"},{"key":"1546_CR5","first-page":"431","volume":"30","author":"PJ Jannetta","year":"1979","unstructured":"Jannetta PJ, Gendell HM. Clinical observations on etiology of essential hypertension. Surg Forum. 1979;30:431\u20132.","journal-title":"Surg Forum"},{"key":"1546_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1172\/JCI100651","volume":"14","author":"IH Page","year":"1935","unstructured":"Page IH, Heuer GJ. A surgical treatment of essential hypertension. J Clin Invest. 1935;14:22\u20136.","journal-title":"J Clin Invest"},{"key":"1546_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00000658-194111440-00018","volume":"114","author":"KS Grimson","year":"1941","unstructured":"Grimson KS. Total thoracic and partial to Total lumbar Sympathectomy and celiac Ganglionectomy in the treatment of hypertension. Ann Surg. 1941;114:753\u201375.","journal-title":"Ann Surg"},{"key":"1546_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11906-017-0755-9","volume":"19","author":"J Jordan","year":"2017","unstructured":"Jordan J. Device-based approaches for the treatment of arterial hypertension. Curr Hypertens Rep. 2017;19:59.","journal-title":"Curr Hypertens Rep"},{"key":"1546_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jash.2015.10.002","volume":"9","author":"C Yerasi","year":"2015","unstructured":"Yerasi C, Baker NC, Jonnalagadda AK, et al. Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial. J Am Soc Hypertens. 2015;9:959\u201365.","journal-title":"J Am Soc Hypertens"},{"key":"1546_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jash.2014.12.002","volume":"9","author":"M Epstein","year":"2015","unstructured":"Epstein M, de Marchena E. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the \"end of the road\" for renal denervation? J Am Soc Hypertens. 2015;9:140\u20139.","journal-title":"J Am Soc Hypertens."},{"key":"1546_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1161\/HYPERTENSIONAHA.114.05010","volume":"65","author":"M Bohm","year":"2015","unstructured":"Bohm M, Mahfoud F, Ukena C, et al. First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015;65:766\u201374.","journal-title":"Hypertension"},{"key":"1546_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2014.03.059","volume":"64","author":"K Sakakura","year":"2014","unstructured":"Sakakura K, Ladich E, Cheng Q, et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol. 2014;64:635\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"1546_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jacc.2014.07.937","volume":"64","author":"AR Tzafriri","year":"2014","unstructured":"Tzafriri AR, Mahfoud F, Keating JH, et al. Innervation patterns may limit response to endovascular renal denervation. J Am Coll Cardiol. 2014;64:1079\u201387.","journal-title":"J Am Coll Cardiol"},{"key":"1546_CR14","doi-asserted-by":"crossref","unstructured":"Lu J, Wang Z, Zhou T, et al. Selective proximal renal denervation guided by autonomic responses evoked via high-frequency stimulation in a preclinical canine model. Circ Cardiovasc Interv. 2015;8.","DOI":"10.1161\/CIRCINTERVENTIONS.115.001847"},{"key":"1546_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jama.2009.1268","volume":"302","author":"J Daniels","year":"2009","unstructured":"Daniels J, Gray R, Hills RK, et al. Laparoscopic uterosacral nerve ablation for alleviating chronic pelvic pain: a randomized controlled trial. JAMA. 2009;302:955\u201361.","journal-title":"JAMA."},{"key":"1546_CR16","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.jacc.2013.02.050","volume":"61","author":"Q Wang","year":"2013","unstructured":"Wang Q, Guo R, Rong S, et al. Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a pre-clinical canine model. J Am Coll Cardiol. 2013;61:2185\u201392.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1546_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.ajkd.2016.01.021","volume":"68","author":"RC Gerber","year":"2016","unstructured":"Gerber RC, Bachler CD, Kraus MA, Sundaram CP. Laparoscopic renal denervation for uncontrolled hypertension due to medication intolerance: a case report. Am J Kidney Dis. 2016;68(1):131\u20133.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1546_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/02656736.2018.1468037","volume":"35","author":"E Ye","year":"2018","unstructured":"Ye E, Baik J, Lee S, Ryu SY, Yang S, Choi EK, Song WH, Yuk HD, Jeong CW, Park SM. Design and simulation of novel laparoscopic renal denervation system: a feasibility study. Int J Hyperth. 2018;35(1):9\u201318.","journal-title":"Int J Hyperth"},{"key":"1546_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/01.HYP.0000103160.35395.9E","volume":"43","author":"MP Schlaich","year":"2004","unstructured":"Schlaich MP, Lambert E, Kaye DM, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension. 2004;43:169\u201375.","journal-title":"Hypertension"},{"key":"1546_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00270-013-0570-x","volume":"36","author":"F Streitparth","year":"2013","unstructured":"Streitparth F, Walter A, Stolzenburg N, et al. MR-guided periarterial ethanol injection for renal sympathetic denervation: a feasibility study in pigs. Cardiovasc Intervent Radiol. 2013;36:791\u20136.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1546_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4244\/EIJV9I1A20","volume":"9","author":"TA Fischell","year":"2013","unstructured":"Fischell TA, Vega F, Raju N, et al. Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model. EuroIntervention. 2013;9:140\u20137.","journal-title":"EuroIntervention"},{"key":"1546_CR22","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","volume":"390","author":"RR Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160\u201370.","journal-title":"Lancet"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01546-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01546-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01546-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T19:29:02Z","timestamp":1623353342000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01546-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1546"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01546-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18963\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18963\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18963\/v3","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"8 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments are conformed to the \u201cPosition of the American Heart Association on Research Animal Use\u201d (November 11, 1984) and approved by the University Committee on Animal Care of Soochow University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests. Boxin Xue holds one patent involving a surgical instrument for laparoscopy (Patent ID: ZL200820238243).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}